Correlation Between Day One and Adagene
Can any of the company-specific risk be diversified away by investing in both Day One and Adagene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Adagene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Adagene, you can compare the effects of market volatilities on Day One and Adagene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Adagene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Adagene.
Diversification Opportunities for Day One and Adagene
Weak diversification
The 3 months correlation between Day and Adagene is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Adagene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adagene and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Adagene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adagene has no effect on the direction of Day One i.e., Day One and Adagene go up and down completely randomly.
Pair Corralation between Day One and Adagene
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.54 times more return on investment than Adagene. However, Day One Biopharmaceuticals is 1.84 times less risky than Adagene. It trades about -0.09 of its potential returns per unit of risk. Adagene is currently generating about -0.23 per unit of risk. If you would invest 1,447 in Day One Biopharmaceuticals on August 29, 2024 and sell it today you would lose (93.00) from holding Day One Biopharmaceuticals or give up 6.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Adagene
Performance |
| Timeline |
| Day One Biopharmaceu |
| Adagene |
Day One and Adagene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Adagene
The main advantage of trading using opposite Day One and Adagene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Adagene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adagene will offset losses from the drop in Adagene's long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Adagene vs. Aerovate Therapeutics | Adagene vs. Acrivon Therapeutics, Common | Adagene vs. Rezolute | Adagene vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |